First Trust Advisors LP United Therapeutics Corp Transaction History

First Trust Advisors LP

  • $95.8 Billion
  • Q1 2024

A detailed history of First Trust Advisors LP transactions in United Therapeutics Corp stock. As of the latest transaction made, First Trust Advisors LP holds 295,756 shares of UTHR stock, worth $93.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
295,756
Previous 287,020 3.04%
Holding current value
$93.8 Million
Previous $63.1 Million 7.65%
% of portfolio
0.07%
Previous 0.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$210.76 - $249.51 $1.84 Million - $2.18 Million
8,736 Added 3.04%
295,756 $67.9 Million
Q4 2023

Feb 13, 2024
SELL
$214.88 - $256.94 $6.26 Million - $7.49 Million
-29,142 Reduced 9.22%
287,020 $63.1 Million
Q3 2023

Nov 13, 2023
SELL
$211.82 - $248.24 $20.4 Million - $23.8 Million
-96,075 Reduced 23.31%
316,162 $71.4 Million
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $17.9 Million - $20.3 Million
87,031 Added 26.76%
412,237 $91 Million
Q1 2023

May 15, 2023
SELL
$212.99 - $276.17 $25.8 Million - $33.4 Million
-121,030 Reduced 27.12%
325,206 $72.8 Million
Q4 2022

Feb 09, 2023
BUY
$205.95 - $280.43 $11.5 Million - $15.6 Million
55,798 Added 14.29%
446,236 $124 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $32.3 Million - $38.8 Million
-158,712 Reduced 28.9%
390,438 $81.8 Million
Q2 2022

Aug 12, 2022
BUY
$174.81 - $241.14 $23 Million - $31.7 Million
131,647 Added 31.53%
549,150 $129 Million
Q1 2022

May 13, 2022
SELL
$166.16 - $213.96 $16.3 Million - $21 Million
-97,934 Reduced 19.0%
417,503 $74.9 Million
Q4 2021

Feb 08, 2022
BUY
$184.32 - $216.08 $3.62 Million - $4.25 Million
19,648 Added 3.96%
515,437 $111 Million
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $1.18 Million - $1.41 Million
-6,577 Reduced 1.31%
495,789 $91.5 Million
Q2 2021

Aug 16, 2021
SELL
$170.47 - $211.93 $22.2 Million - $27.6 Million
-130,195 Reduced 20.58%
502,366 $90.1 Million
Q1 2021

May 14, 2021
SELL
$153.94 - $174.85 $33 Million - $37.5 Million
-214,239 Reduced 25.3%
632,561 $106 Million
Q4 2020

Feb 02, 2021
SELL
$101.87 - $151.79 $47,063 - $70,126
-462 Reduced 0.05%
846,800 $129 Million
Q3 2020

Nov 05, 2020
BUY
$99.9 - $121.13 $22.3 Million - $27 Million
223,194 Added 35.76%
847,262 $85.6 Million
Q2 2020

Jul 22, 2020
BUY
$92.74 - $125.82 $1.38 Million - $1.87 Million
14,837 Added 2.44%
624,068 $75.5 Million
Q1 2020

May 06, 2020
SELL
$79.39 - $115.35 $662,350 - $962,365
-8,343 Reduced 1.35%
609,231 $57.8 Million
Q4 2019

Feb 03, 2020
SELL
$78.31 - $95.34 $14.6 Million - $17.8 Million
-186,625 Reduced 23.21%
617,574 $54.4 Million
Q3 2019

Nov 04, 2019
SELL
$74.85 - $85.99 $30.4 Million - $34.9 Million
-405,955 Reduced 33.55%
804,199 $64.1 Million
Q2 2019

Jul 30, 2019
SELL
$76.06 - $120.81 $6.12 Million - $9.72 Million
-80,436 Reduced 6.23%
1,210,154 $94.5 Million
Q1 2019

May 09, 2019
BUY
$107.15 - $126.84 $10 Million - $11.9 Million
93,786 Added 7.84%
1,290,590 $151 Million
Q4 2018

Feb 07, 2019
BUY
$101.4 - $128.73 $14.5 Million - $18.4 Million
143,235 Added 13.6%
1,196,804 $130 Million
Q3 2018

Oct 25, 2018
BUY
$113.81 - $129.46 $42 Million - $47.7 Million
368,613 Added 53.82%
1,053,569 $135 Million
Q2 2018

Aug 02, 2018
BUY
$101.14 - $118.31 $18.4 Million - $21.6 Million
182,409 Added 36.3%
684,956 $77.5 Million
Q1 2018

Apr 23, 2018
SELL
$107.21 - $151.94 $2.1 Million - $2.97 Million
-19,546 Reduced 3.74%
502,547 $56.5 Million
Q4 2017

Feb 08, 2018
BUY
$118.58 - $151.28 $6.87 Million - $8.77 Million
57,941 Added 12.48%
522,093 $77.2 Million
Q3 2017

Oct 24, 2017
BUY
$114.6 - $136.81 $53.2 Million - $63.5 Million
464,152
464,152 $54.4 Million

Others Institutions Holding UTHR

# of Institutions
561
Shares Held
43.1M
Call Options Held
501K
Put Options Held
529K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email